AYX News and Press, Alteryx Inc. Class A From 05/18/21

Alteryx Introduces Alteryx Ventures for Strategic Investments in Companies Innovating in Analytics, Data Science and Analytical Applications New Alteryx Corporate Ventures Fund Will Help Startups Accelerate Innovation in Areas that Complement Alteryx's Strategy and Vision PR...

Alteryx, once one of the high-growth companies in the area of data analytics, was heavily impacted by COVID-19, and revenue growth has evaporated. The new CEO is changing strategy to focus on the enterprise. ARR guidance is still near 30% growth. Give the new CEO some time. Given ...

Palantir (PLTR) has the potential to become one of the key central operating systems of US government and other major organizations. Palantir's share price is down nearly 48% since its recent peak. Current sell off provides an attractive entry opportunity. Our valuation analysis s...

Despite a slight bump following better-than-expected first-quarter results, Alteryx 's (NYSE: AYX) stock price is down by close to 60% from its last-year all-time high. Some might consider taking advantage of the discount. But before investors buy in, they should pay close attention...

Alteryx Appoints Paula Hansen as Chief Revenue Officer Former SAP CRO and Cisco Executive Joins Company to Lead Global Go-to-Market Organization PR Newswire IRVINE, Calif. , May 10, 2021 /PRNewswire/ -- Alteryx, Inc. (NYSE: AYX), the analytics automation ...

Even before the pandemic, the world was becoming more and more digitized. New innovations such as cloud computing, artificial intelligence, and 5G communications are opening up new ways to work and interact with customers, and the COVID-19 global pandemic only accelerated these powerful tre...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips What Happened to the Alteryx Stock Price Today? Shares of data analytics provider Alteryx (NYSE: AYX ) popped after the company reported strong first quarter numbers , with AYX stock rising nearly 10% on the day....

Alteryx (AYX) is up 7.5%, continuing the rally after yesterday's Q1 beats with a narrower expected loss per share.Rosenblatt maintains a Buy rating on Alteryx but lowers the price target from $145 to $130. Analyst Blair Abernethy praised the beats but lowered the target due to lower soft...

Chiasma (CHMA) +39% on Q1 results.Athenex (ATNX) +31% on Kuur Therapeutics acquisition.Ault Global Holdings (DPW) +30% on preliminary Q1 results.iBio (IBIO) +26% after resolving Fraunhofer USA lawsuitBig 5 Sporting Goods Corporation (BGFV) +22% on Q1 results.DAVIDsTEA...

The following slide deck was published by Alteryx, Inc. in conjunction with their 2021 Q1 earnings call. For further details see: Alteryx, Inc. 2021 Q1 - Results - Earnings Call Presentation